Symptoms of Ovarian Cancer: Early Signs, Risk Factors, and Genetic Testing
At a Glance
- Sample Required: Blood or saliva (for genetic testing)
- Fasting: Not required
- Turnaround Time (TAT): 7–10 business days for genetic testing
- Base Cost: ₹12,000 – ₹25,000 (depending on panel)
Ovarian cancer originates in the ovaries—the female reproductive glands located in the pelvis. It is relatively rare compared to other gynecologic cancers, but it is notoriously difficult to detect early because symptoms are often subtle and mimic common benign conditions. This guide provides a comprehensive overview of ovarian cancer symptoms, risk factors, and the critical role of genetic testing in early detection and prevention.
Common Symptoms and Red Flags
The following symptoms are frequently reported by women diagnosed with ovarian cancer. However, they are nonspecific and can be caused by many other conditions. The key is persistence and frequency—if you experience any of these symptoms more than 12 times per month, consult a gynecologist.
| Symptom | Description | When to Seek Medical Advice |
|---|---|---|
| Abdominal or pelvic pain | Persistent pain or discomfort in the lower abdomen or pelvis | If pain is new, persistent, and not related to menstrual cycle |
| Bloating / fullness | Feeling bloated or full even after a light meal | If bloating occurs daily for more than 2 weeks |
| Increased abdominal girth | Noticeable increase in waist size or abdominal swelling | If accompanied by other symptoms or rapid onset |
| Urinary urgency/frequency | Feeling the need to urinate more often or urgently | If persistent and not due to urinary tract infection |
| Constipation or diarrhea | Changes in bowel habits lasting more than a few weeks | If accompanied by abdominal pain or blood in stool |
| Fatigue | Unexplained, persistent tiredness | If severe and interferes with daily activities |
| Unexplained weight changes | Weight loss or gain without diet/exercise changes | If more than 5% change in 6 months |
| Abnormal vaginal bleeding | Postmenopausal bleeding, heavy periods, or bleeding between periods | Always warrants immediate gynecologic evaluation |
| Back pain | Lower back pain not related to injury or strain | If persistent and accompanied by other symptoms |
| Indigestion / nausea | Persistent upset stomach, gas, or nausea | If not relieved by antacids and persists |
Risk Factors and Genetic Predisposition
Several factors increase the likelihood of developing ovarian cancer. The most significant are:
- Age: Most cases occur in women over 50, with peak incidence in the 60s.
- Family history: A first-degree relative (mother, sister, daughter) with ovarian or breast cancer increases risk.
- Inherited genetic mutations: Pathogenic variants in BRCA1 and BRCA2 account for about 10–15% of all ovarian cancers. Women with BRCA1 mutations have a 39–44% lifetime risk; with BRCA2, 11–17%.
- Other genetic syndromes: Lynch syndrome (MLH1, MSH2, etc.) also elevates risk.
- Reproductive history: Early menarche, late menopause, or nulliparity (never giving birth) may increase risk.
- Endometriosis: Associated with a higher risk of certain ovarian cancer subtypes.
If you have a strong family history or known genetic mutation, genetic counseling and testing are strongly recommended. DNA Labs India offers comprehensive hereditary cancer panels using Next-Generation Sequencing (NGS) and Whole Exome Sequencing (WES) to identify pathogenic variants in BRCA1, BRCA2, and 30+ other cancer susceptibility genes.
Screening and Diagnostic Approaches
Routine screening for ovarian cancer is not recommended for the general population due to the low prevalence and high false-positive rates of available tests. However, for high-risk women (known mutations, strong family history), the following may be considered:
- Transvaginal ultrasound (TVUS): Visualizes ovarian morphology and detects masses.
- CA-125 blood test: Measures a tumor marker, but it is not specific and can be elevated in benign conditions. It is primarily used for monitoring treatment response, not for screening.
- Genetic testing: Identifies inherited mutations that guide risk-reduction strategies (e.g., prophylactic salpingo-oophorectomy).
For symptomatic women, diagnosis typically involves imaging (TVUS or CT) and biopsy if a suspicious mass is found. Early-stage ovarian cancer is often asymptomatic, which underscores the importance of recognizing persistent symptoms and discussing genetic risk with your physician.
Treatment Overview
Treatment depends on the stage, histology, and genetic profile of the tumor. Standard options include:
- Surgery: Debulking surgery to remove visible tumor is the cornerstone.
- Chemotherapy: Platinum-based regimens (carboplatin/paclitaxel) are standard.
- Targeted therapy: PARP inhibitors (e.g., olaparib) are effective in BRCA-mutated tumors.
- Radiation therapy: Less commonly used, but may be indicated in specific cases.
Genetic testing of the tumor (somatic testing) can also reveal actionable mutations, guiding personalized treatment.
When to See a Doctor
If you experience any of the symptoms listed above more than 12 times per month, especially if they are new and persistent, schedule an appointment with a gynecologist. Early consultation can lead to earlier diagnosis and better outcomes. For women with a family history of ovarian or breast cancer, genetic counseling is recommended regardless of symptoms.